PDEX vs TLRY · P/E 16, rev $77.5M vs rev $915.5M
Pro-Dex Inc (PDEX) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Pro-Dex Inc (PDEX) is a medical instruments & supplies company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PDEX revenue for 2026-06-30 was $77.5M. Net income was $13.7M. Revenue was up 16.5% from 2025-06-30 to 2026-06-30. PDEX currently screens at market cap $146.4M and trailing P/E 16.3.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
PDEX currently screens at market cap $146.4M and trailing P/E 16.3. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the PDEX and TLRY stock pages for the full models.
Not investment advice.